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Abstract. To screen differentially expressed genes quickly and efficiently in breast cancer, two gene microarray 
datasets of breast cancer, GSE15852 and GSE45255, were downloaded from GEO. This paper proposed a novel 
method named LR-RF to select differentially expressed genes of breast cancer on microarray data by the Bonferroni 
test of FWER error measure. Comparing with Logistic Regression and Random Forest, our study shows that LR-FR 
has great facility in selecting differentially expressed genes. The average prediction accuracy of the proposed LR-RF 
from replicating random test ten times surprisingly reaches 93.11% with variance as low as 0.00045.  In addition, 
through analyzing the gene interaction networks, most of the top 20 genes we selected were found to involve in the 
development of breast cancer. All of these results demonstrate the reliability and efficiency of LR-RF. It is 
anticipated that LR-RF would provide new knowledge and method for biologists, medical scientists, and cognitive 
computing researchers to identify disease-related genes of breast cancer. 
Keywords: breast cancer, differentially expressed genes, Logistic Regression-Random Forest, Bonferroni test, gene 
interaction networks. 
1 Introduction 
Breast cancer is the most common cancer in women worldwide. Across the globe, breast cancer is 
the second most common type of cancer and the second leading cause of cancer death in women. 
According to the latest statistics, every 26 seconds, there is a woman diagnosed with breast cancer. 
New breast cancer worldwide each year is up to 1.2 million, with an average annual increase in 
500,0001. For the prevention of breast cancer, early diagnosis and treatment, different ways from 
biomedical, bioinformatics, and so on are urgently needed in identifying the cancer-causing genes. 
 
With the rapid development of sequencing technologies, a large amount of biological information 
has been stored in the gene expression data. Gene chip, also known as DNA microarray, is one of the 
most important technologies in the field of life science researches2-4. In fact, based on the extensive 
application of gene chip technology, the network of public databases in the growing gene chip 
expression data can provide an enormous powerful tool for breast cancer gene expression analysis. At 
the same time, the abnormal expression of polygene is the crucial biological factor of the occurrence 
and progression of breast cancer. The analysis of differential expression genes and their interaction 
networks of breast cancer is of practical significance to study the pathogenesis of breast cancer in depth, 
guide the individual treatment and improve the prognosis of breast cancer patients. 
Actually, one of the important tasks of gene chip profiling data analysis is to screen for 
differentially expressed genes. For example, by comparing the differences in gene transcription and 
expression between normal and disease states in the study of the pathogenesis of the disease, doctors 
can conduct early diagnosis and treatment of the disease, and even predict the prognosis for patients.  
Currently, those methods suitable for different study design and data type gene expression profiles to 
screen differentially expressed genes for gene expression profiles include SAM (significance analysis 
of microarrays)5, two-sample t-test6, and so on.  However, false positive of the differential expression 
genes by using the SAM and two sample t-test are too high. Actually, earlier researchers have tried to 
select differentially expressed genes by Logistic Regression (LR)7-9, or Random Forest 
(RF).10-12Although LR is one of the classical methods and has been widely used for classification, the 
traditional LR model employs all (or most) variables for predicting and screening the differentially 
expressed genes, so requires selecting many redundant genes. On the other hand, some researchers 
applied RF to classify genes from microarray data and did not pre-select genes but result in overfitting 
due to the availability of gigantic gene data and dimensionality.  
To take account of different consequences of existing methods in identifying differentially 
expressed genes related to breast cancer, a new method, named LR-RF method, is proposed based on 
microarray data in this article. Firstly, we pre-select genes by LR and get a series of differentially 
expressed genes based on the Bonferroni test13 of the Family Wise Error Rate (FWER)14 error measure. 
Then, best-related genes of differentially expressed of breast cancer are identified by RF method. 
Finally, by analyzing gene interaction networks, the LR-RF method is found to have an excellent 
performance for identifying differentially expressed genes. 
2 Materials and methods 
2.1 Materials 
In this paper, we have downloaded two sets of breast cancer datasets from Gene Expression 
Omnibus (GEO) 15.The accession numbers were GSE15852 and GSE45255, and the chip platform was 
GPL96. Dataset GSE15852 included 43 paired normal persons and breast cancer patients. Dataset 
GSE45255 consisted of 139 breast cancer patients. By integrating data, there were 182 breast cancer 
patients and 43 normal cases for subsequent analysis and each of them contains 22215 genes. 
In general, each gene has a different expression level, and gene expression value doesn’t have a 
unified norm due to differences in the experiments on the microarray data. Thus, we normalize the 
microarray data by MAPMINMAX function in the MATLAB. The MAPMINMAX processes 
matrices by normalizing the minimum and maximum values of each row to [ min max[ , ]y y . The formula 
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In this study, we set min 0y = , max 1y =  and standardize the data to the internal [0, 1]. 
2.2 Methods 
In this section, the Bonferroni test of FWER measure is briefly reviewed firstly. Further, we 
introduce the typical LR model and RF model. Lastly, a novel method LR-RF is proposed to screen 
differentially expressed genes. For all of the microarray data, we pre-select genes by LR method to 
reduce the dataset dimensions and then use a RF classifier to identify cancer-causing genes. 
2.2.1 Bonferroni test of FWER error measure 
Regression analysis for a single hypothesis usually has a straightway interpretation of the testing 
result, but this may become much complicated for multiple hypotheses in a regression model based 
analysis. While each test of the multiple hypotheses has its type I and type II errors, and then it 
becomes unclear how to measure the overall error rate. FWER, which is the probability of making one 
or more type I errors among all the hypotheses, is the first measure being suggested for dealing with 
this issue. In this paper, the Bonferroni test based on the FWER measure was used to screen the 
differentially expressed genes. 
The Bonferroni inequality16 is often used when conducting multiple tests of significance to set an 
upper bound on the overall significance levelα . If 1, , nT T is a set of n  statistics with corresponding 
p-values 1, , nP P  for testing hypothesis 1, , nH H , the classical Bonferroni multiple test procedure 
is usually performed by rejecting 0 1{ , , }nH H H=   if any p-values is less than nα . Furthermore 
the specific hypothesis iH  is rejected for each iP nα≤ ( 1, ,i n=  ).The Bonferroni inequality is in 
the following. 
1
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It is to ensure that the probability of rejecting at least one hypothesis when all true is no greater 
than α .
 
2.2.2 Logistic Regression model 
LR17 models are the most widely used models in the generalized linear models family. A LR 
model is used when the response Y  is a binary variable taking only two possible values, such as the 
binary classification between normal and tumor considered in this paper. 
 
 Because the dependent variable Y  only takes two discrete values 0, 1, it is not suitable for the 
regression model as a dependent variable. The basic idea of LR is that it does not regress toY  directly, 
but rather defines a probability function: 
1 1 2 2Pr( 1 | , , , )i iY X x X x X xπ = = = = =                  (4) 
where there requires 0 1π≤ ≤ . Directly seeking the expression of π  is a very difficult, we consider 
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π is a Logistic type of function. Then, we deform it and get a new function as follow: 
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where ( )f x  is a continuous curve limited to the [0, 1] interval. 
 
In this article, the regression is relatively column by column, so the probability equation is: 
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where iX  is the i-th gene value information, and π  is the probability of being sick. 
2.2.3 Random Forest model 
RF is an algorithm for classification developed by Leo Breiman 18 that uses an ensemble of 
classification trees. Each of the classification trees is built using a bootstrap sample of the data, and 
each split the candidate set of variables is a random subset of the variables. Thus, RF uses both bagging 
(bootstrap aggregation), a successful approach for combining unstable learners, and random variable 
selection for tree building. Each tree is unpruned (grown fully) to obtain low-bias trees. At the same 
time, bagging and random variable selection result in the low correlation of the individual trees. The 
algorithm yields an ensemble that can achieve both low bias and low variance. 
2.2.4 Logistic Regression-Random Forest model 
In this section, the LR-RF model is proposed. The model can be divided in two steps. 
The first step: we pre-select genes by LR, based on the Bonferroni test of FWER error measure, 
and we get a series of differentially expressed genes roughly. The second step: we use the RF algorithm 
for the second screening and get the top potential genes related to breast cancer. As a matter of fact, RF 
can identify which genes were important in building a forest of trees and get the genes’ importance 
score ranking to determine whether it is used in the model. So setting a threshold and determining the 
importance, we delete any genes with an importance below the threshold. Through the two steps, the 
differentially expressed genes in breast cancer can be obtained. 
 
Fig.1. the process for LR-RF model 
3 Results and analysis 
3.1 Differentially expressed genes  
For these three methods, we conducted 10 random tests and each test took 80% of the data as a 
training set, and the remaining 20% data as a testing set. 
By screening, each method yielded a different number of differentially expressed genes, as 
showed in Table 1. In this study, we set 0.1 as the threshold when use the RF method to select genes. 
Table 1.The number of differentially expressed genes selected by the three methods 
Ten random tests 
Method 
1 2 3 4 5 6 7 8 9 10 
LR 102 240 372 143 371 629 197 257 233 288 
RF 22 33 19 24 27 14 17 25 23 20 
LR-RF 102 188 158 133 143 107 174 142 163 137 
The number of the differentially expressed genes selected by the three methods is listed in Table 1. 
A large number of genes selected by LR method are redundant genes. Although the RF method can 
screen out few differentially expressed genes, model may cause over fitting and then loss quite 
important genes due to the high dimensionality of the microarray data. In contrast, the LR-RF method 
can select important genes from the cancer-causing genes that have been pre-selected by the LR 
method, and guarantee the assurance of the veracity of identifying differential expression genes 
according to RF model. 
3.2 Stability analysis of the three methods 
Using the differential expression genes screened to predict whether the testing set samples are 
breast cancer patients. In this paper, the Rand index19 is applied to calculate the prediction accuracy 
rate.  
a：The patient is predicted to be a patient. 
b：The patient is predicted to be normal. 
c：The normal person is predicted to be a patient. 
d：The normal person is predicted to be normal. 
The prediction accuracy=
a d




Through validating and comparing the models, we can get the prediction accuracy rate of the three 
methods and evaluate the stability of the method by using the variance of accuracy. The smaller the 
variance is, the more stable the method is. 
Table 2.The prediction accuracy rate and stability of the three methods 
Ten random tests 
Method 
1 2 3 4 5 6 7 8 9 10 average variance 
LR 90.2 91.9 89.2 93.0 96.3 85.4 96.2 96.0 93.3 92.2 92.37 0.0011 
RF 84.4 82.2 91.1 88.9 88.9 82.2 91.1 86.7 84.4 80.0 85.99 0.0014 
LR-RF 95.6 93.3 91.1 91.1 93.3 95.6 93.3 93.3 95.6 88.9 93.11 0.00045 
(Note: the unit of 2 to 12 columns is %.) 
Seen from Table 2, the average prediction accuracy rate of the LR-RF method is 93.11%, which is 
higher than LR and RF methods. The variance of the LR-RF method is 0.00045, and the variances of 
the LR and RF are 0.0011, 0.0014, respectively. LR-RF method’s variance is smaller than the other 
methods’ variances. Obviously, comparing with the other two methods, the method LR-RF we 
proposed is more stable on the premise that selecting differentially expressed genes effectively. 
Remark: the average prediction accuracy rate of the RF method is 85.99%, it is because the 
differentially expressed genes selected by the RF method are too few including true disease-related 
genes have been deleted, and ones selected by the LR method too many genes. The average prediction 
accuracy rate doesn’t vary much between LR method (92.37%) and LR-RF method (93.11%), but the 
number of the genes selected by the LR-RF method is smaller than the LR method. Compared with 
the LR method, the differentially expressed genes system built by the LR-RF is simpler. 
3.3 Hierarchical clustering analysis 
We took the union of the differentially expressed genes selected by LR-RF methods ten times, and 
the clustering analysis was performed by using R software. The hierarchical clustering chart was as 
follows: 
 
Fig.2. The heat map of cluster analysis of differentially expressed genes of 139 breast cancer patients and 43 normal 
specimens. 
The 225 samples are clustered into two groups using differentially expressed genes selected by the 
LR-RF method. The 139 samples ahead of the figure are breast cancer patients and the remaining 
samples are 43 normal specimens. It can be seen that a significant difference between the two groups in 
Fig.2.This indicates these genes can distinguish the normal samples from and patient ones. 
3.4 The analysis of genes interaction networks 
Top 20 differentially expressed genes related to breast cancer selected by our method is listed in 
Table3. The most exciting results from the table, majority of genes had been described in accumulating 
papers of breast cancer. 













1 201650 KRT19 1.155279813 11 218168 ADCK3 0.399596245 
2 209493 PDZD2 0.641707676 12 216379 CD24 0.383872561 
3 209763 CHRDL1 0.57484195 13 215695 GYG2 0.37417914 
4 206488 CD36 0.567017651 14 214439 BIN1 0.374115711 
5 211696 HBB 0.53992312 15 43427 ACACB 0.360580478 
6 207092 LEP 0.489604283 16 218723 RGCC 0.34986191 
7 205478 PPP1R1A 0.471361386 17 210201 BIN1 0.342833509 
8 203548 LPL 0.436124485 18 219140 RBP4 0.332710044 
9 203853 GAB2 0.420885256 19 221009 ANGPTL4 0.31555432 
10 209699 AKR1C2 0.408219183 20 204894 AOC3 0.297631023 
Previous research has identified a highly deregulated gene Keratin 19(KRT19) in breast cancer. 
Furthermore, KRT19 expression was associated with breast tumor subtyping, among estrogen 
receptor(ER) and Luminal B, and KRT19 expression correlated with poor overall survival20-24. PDZ 
domain containing 2(PDZD2) does not possess an intrinsic enzymatic activity through a number of 
direct and indirect interactions with breast tumor suppressors. It inhibits the activities of P and PDZ 
proteins, or enhances the activity of telomerase.25 Other studies suggest that the CD36 gene26 is located 
on the chromosome 7q11.2, and its encoded protein CD36 molecule is a transmembrane glycoprotein 
expressed on the surface of platelets and a variety of tumor cells. Seewaldt et al27 found that inhibition 
of CD36 gene expression in normal breast cells can lead to a decrease in adipocyte surrounding cells 
and an increase in extracellular matrix collagen deposition, which is a key factor in increased 
mammalian gland density, and the lack of CD36 gene infection may be an important event in the early 
development of breast cancer. 
To further demonstrate the predictive ability of LR-RF, we annotated the differentially expressed 
genes screened by LR-RF method to Gene MANIA database and found that most of these genes were 
significantly enriched in pathways related to the breast cancer, such as adipocytokine signaling pathway, 
neurotrophin signaling pathway. This demonstrates these genes play important roles in the cancers. 
 
Fig.3. Network of the differentially expressed genes constructed by Gene MANIA 
 
  Physical interactions       Co-expression      Predicted      Pathway 
Fig.4. Network of the PDZD2 gene constructed by Gene MANIA 
In Fig.4, the differentially expressed genes are involved in many known pathways and harbor 
many physical interactions. From the two figures we can see, these differentially expressed genes are 
densely connected which several, such as PDZD2, LPL and CD36 have been confirmed to be closely 
related to breast cancer. Fig.4 also shows that the interaction network of PDZD2 gene with other genes 
can be seen clearly. 
4 Conclusions 
It is well known that many cancer-causing genes of breast cancer are still unclear. However it is 
crucial to select the differentially expressed genes by bioinformatics methods from the availability of 
huge DNA microarray data. We have found candidate genes related to breast cancer based on 
microarray data and proposed a method for screening differentially expressed genes of breast cancer by 
combining LR and RF as a machine-learning technique. From 22215 genes of breast cancer, we 
pre-select a series of differentially expressed genes, and then screen breast cancer genes again. LR and 
RF have been trained before and after screening differentially expressed genes. The LR-RF method 
greatly improves not only the accuracy of the screening of cancer-causing genes but also the speed. 
Via replicating a random experiment ten times, two microarray datasets related to breast cancer 
have been used to measure the stability of methods by using variance. The analyses show that the 
proposed mixed model can produce almost similar pattern of results for all considered selections, and 
select differentially expressed genes successfully. 
Although some genes including in the results have not been identified, LR-RF is shown to  have the 
potential to screen differentially expressed genes related to breast cancer efficiently in a short time. It is 
anticipated that LR-RF would provide new knowledge and method for biologists, medical scientists, and cognitive 
computing researchers to identify disease-related genes of breast cancer. 
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